Kirsty Graham
Kirsty Graham

Kirsty Graham, global CEO of Edelman’s practice and sectors unit, will take over the US operation on Feb.1.

She succeeds Lisa Osborne Ross, who took a “leave of absence” in September and exited the firm in October.

Graham was in charge of strategy for Edelman’s global brand and health, technology, energy and food & beverage sectors.

She has chaired the global health operation since joining Edelman in 2020 from Pfizer, where she was SVP-corporate affairs for their biopharmaceuticals group.

At Pfizer, Graham handled policy, PA and communications for the medicines business, operating in more than 125 countries with a portfolio of more than 600 products.

As the head of Edelman’s biggest region, Graham will oversee about 2,500 staffers in a dozen offices from her perch in New York.

She will report to Matthew Harrington, global president/COO and acting US CEO.